| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 06/01/2011 | EP1379510B1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chemosensitizers |
| 06/01/2011 | CN101298434B Chinoline coordination high polymer material, preparation and use thereof |
| 05/31/2011 | US7951950 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 05/31/2011 | US7951947 Light-emitting material comprising orthometalated iridium complex, light-emitting device, high efficiency red light-emitting device, and novel iridium complex |
| 05/31/2011 | US7951946 Light-emitting material comprising orthometalated iridium complex, light-emitting device, high efficiency red light-emitting device, and novel iridium complex |
| 05/31/2011 | US7951945 Light-emitting material comprising orthometalated iridium complex, light-emitting device, high efficiency red light-emitting device, and novel iridium complex |
| 05/31/2011 | US7951820 Triazole compounds useful as protein kinase inhibitors |
| 05/31/2011 | CA2507657C 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists |
| 05/31/2011 | CA2319080C Multivalent antibacterial agents |
| 05/31/2011 | CA2172282C Chiral surfactants and methods for their use in chiral separations |
| 05/26/2011 | WO2011063233A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| 05/26/2011 | WO2011061292A1 A process for a preparation of marbofloxacin and intermediate thereof |
| 05/26/2011 | US20110124870 Novel mycobacterial inhibitors |
| 05/26/2011 | US20110124869 Process for Preparing Modulators of Cystic Fibrosis Transmembrane Conductance Regulator |
| 05/26/2011 | US20110124731 Treatment Of Neurodegenerative Diseases And Cancer Of The Brain Using Histone Deacetylase Inhibitors |
| 05/26/2011 | US20110124673 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 05/26/2011 | US20110124085 Unsymmetrical cyanine dimer compounds and their application |
| 05/25/2011 | EP2325279A2 Electroluminescent iridium compounds |
| 05/25/2011 | EP2325171A1 Quinoline derivatives for treating retinal diseases |
| 05/25/2011 | EP2325170A1 Substituted quinolinones having herbicidal action |
| 05/25/2011 | EP2324843A1 Use of TNF-alpha inhibitors for treating nerve root injury |
| 05/25/2011 | EP2323661A1 A3 adenosine receptor allosteric modulators |
| 05/25/2011 | CN1849330B Specific glucocorticosteroid compound having anti-inflammatory activity |
| 05/25/2011 | CN1578663B Inhibitors of histone deacetylase |
| 05/25/2011 | CN102076650A Carboxylic acid compound |
| 05/25/2011 | CN102070524A Method for preparing 3-cyano-4-halogenated quinoline derivatives |
| 05/25/2011 | CN102070523A Novel method for preparing 3-hydroxylquinaldine-4-carboxylic acid |
| 05/25/2011 | CN102070522A Quinolone derivatives and application thereof in organic light-emitting devices (OLEDs) |
| 05/25/2011 | CN102070521A Method for preparing quinoline derivative |
| 05/25/2011 | CN102070520A Method for preparing 3-aryl-subsituted quinoline by 3-oxo-2,3-diarylpropionaldehyde |
| 05/25/2011 | CN101475526B Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof |
| 05/25/2011 | CN101337929B Process for synthesizing quinclorac by oxidizing reaction |
| 05/25/2011 | CN101142187B Ionic organic compound |
| 05/25/2011 | CN101128431B Novel quinoline derivatives as potassium ion channel openers |
| 05/24/2011 | US7947712 Antiarthritic agents; asthma; chronic obstructive pulminary diosrders; atherosclerosis; vision defects; hepatitis; central nervous system disorders; cardiovascular disorders; wound healing agents; restenosis; cirrhosis; multiple sclerosis; glomerulonephritis; graft versus host disease; antidiabetic agent |
| 05/24/2011 | US7947711 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 05/24/2011 | CA2472821C Process for producing fused imidazole compound, and reformatsky reagent in stable form and process for producing the same |
| 05/24/2011 | CA2464807C Phenyl-propargylether derivatives |
| 05/24/2011 | CA2443952C Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors |
| 05/24/2011 | CA2393710C Caspase inhibitors and uses thereof |
| 05/19/2011 | WO2011030213A8 Improved process for the preparation of 7-(4-bromobutoxy) 3,4-dihydrocarbostyril, a precursor of aripiprazole |
| 05/19/2011 | US20110118470 Nitrogen-containing aromatic derivatives |
| 05/19/2011 | US20110118469 Continuous flow synthesis of amino alcohols using microreactors |
| 05/19/2011 | US20110118468 Process for producing 6-aryloxyquinoline derivative and intermediate therefor |
| 05/19/2011 | US20110118308 Crystals of laquinimod sodium, and process for the manufacture thereof |
| 05/19/2011 | US20110118270 Heterocyclic derivatives that are used in the treatment of neurodegenerative diseases |
| 05/19/2011 | US20110118260 Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivatives having substituted oxy group |
| 05/19/2011 | US20110117057 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 05/18/2011 | EP2099759B1 Antibacterial quinoline derivatives |
| 05/18/2011 | EP1698618B1 Benzamide derivative |
| 05/18/2011 | EP1466905B1 Process for producing optically active oxoheptenoic acid ester |
| 05/18/2011 | EP1318140B1 Novel amide derivatives and medicinal use thereof |
| 05/18/2011 | CN102066330A Polymorph of 8-hydroxy-5- [(1R)-1-hydroxy-2- [[(1R) -2-(4-methoxyphenyl) -1-methylethyl] amino] ethyl] -2(1H)-quinolinone monohydrochloride |
| 05/18/2011 | CN102066329A Crystal form of 8-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2- (4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)- quinolinone monohydrochloride |
| 05/18/2011 | CN102066325A Heteroaromatic monoamides as orexinin receptor antagonists |
| 05/18/2011 | CN102060852A Quinoline complexes, preparation method thereof, quinoline complex-containing catalyst and use of catalyst in catalysis of vinyl polymerization |
| 05/18/2011 | CN102060851A Method for preparing polyhydroquinolines |
| 05/18/2011 | CN102060790A Quinoxaline double N-oxide derivative ligand and application thereof to promotion on copper-catalyzed C-O coupling reaction |
| 05/18/2011 | CN102060763A Preparation method of micro-powdery aripiprazole crystal form I or II |
| 05/18/2011 | CN102060762A Montelukast compound and new preparation method thereof |
| 05/18/2011 | CN102060761A Method for preparing quinoline |
| 05/18/2011 | CN102060738A Ionic liquid combining B acid site and L acid site as well as preparation method and application thereof |
| 05/18/2011 | CN102060639A Method for preparing nitrogen-containing heterocyclic olefin derivatives |
| 05/18/2011 | CN101602724B 4,4'-bis(5-sulfo-8-hydroxyl-7-aminoquinoline azo)-3,5,3',5'-tetrabromo-diphenyl ether |
| 05/18/2011 | CN101558042B Method of preparing montelukast and intermediates used therein |
| 05/18/2011 | CN101065372B 1-alkynyl-2-aryloxyalkylamides and their use as fungicides |
| 05/17/2011 | USRE42376 Substituted 3-cyanoquinolines |
| 05/17/2011 | US7943777 Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use |
| 05/17/2011 | US7943641 7-((1H-imidazol-4-yl)methyl)-5,6,7,8-tetrahydroquinoline |
| 05/17/2011 | US7943640 3-Fluoro-2-(2-methylsulfanyl-phenyl)-quinolin-4-yl]-pyridin-4-yl-amine; modulating transforming growth factor (TGF) - beta; fibroproliferative diseases or diseases associated with fibrosis; cardiovascular, urogenital and gastrointestinal disorders; antihypotensive, -arthritic agents; angioplasty |
| 05/17/2011 | US7943639 Such as 6-benzenesulfonyl-4-piperazin-1-yl-quinoline hydrochloride; for treatment of central nervous system and/or 5- HT6 receptor related disorders; for weight gain/loss |
| 05/17/2011 | US7943630 3,9-diaza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/17/2011 | US7943605 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses |
| 05/17/2011 | CA2688934C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 05/17/2011 | CA2514267C Malonamide derivatives as gamma-secretase inhibitors |
| 05/17/2011 | CA2470365C 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
| 05/17/2011 | CA2463552C Treatment of neurodegenerative diseases and cancer of the brain |
| 05/12/2011 | WO2011055843A1 Retinoid compound |
| 05/12/2011 | WO2011054848A1 Thetrahydroquinolines derivatives as bromodomain inhibitors |
| 05/12/2011 | WO2011054841A1 Tetrahydroquinoline derivatives and their pharmaceutical use |
| 05/12/2011 | WO2010151710A3 Substituted heterocyclic compounds as kinases inhibitors and method of use thereof |
| 05/12/2011 | WO2010131054A9 Redox drug derivatives |
| 05/12/2011 | US20110112300 Improved process for preparing montelukast and salts thereof |
| 05/12/2011 | US20110112282 Ido inhibitors and therapeutic uses thereof |
| 05/12/2011 | US20110112141 Crystals of laquinimod sodium, and process for the manufacture thereof |
| 05/12/2011 | US20110112140 Inhibitor of plasminogen activator inhibitor-1 |
| 05/12/2011 | US20110112098 Molecules inhibiting a metabolic pathway involving the syk protein tyrosine kinase and method for identifying said molecules |
| 05/12/2011 | US20110112092 Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 05/12/2011 | US20110112084 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 05/12/2011 | US20110112076 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors |
| 05/12/2011 | US20110111959 Pollen tube stimulants from arabidopsis pistils |
| 05/12/2011 | US20110108755 Heteroaromatic phthalonitriles |
| 05/12/2011 | CA2780111A1 Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors |
| 05/11/2011 | EP2319835A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group |
| 05/11/2011 | EP2318371A2 Novel solid state forms of laquinimod and its sodium salt |
| 05/11/2011 | EP2318361A1 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors |
| 05/11/2011 | EP1604665B1 C-kit kinase inhibitor |
| 05/11/2011 | EP1320520B1 Sulfonylguanidine |
| 05/11/2011 | CN102050781A Industrial preparation method of hydroxychloroquine sulfate |
| 05/11/2011 | CN102050780A Quinoline derivatives, and medicament composition and application thereof |